From the publishers of The New England Journal of Medicine

Save time and stay informed. Our physician-editors offer you clinical perspectives on key research and news.

  1. Home>
  2. Specialties>
  3. Dermatology>
  4. Summary and Comment

Thin Melanomas: Going, Going, Gone?

Regression of a thin melanoma may indicate an increased risk for metastasis.

Although Breslow thickness is clearly the best predictor of metastasis in melanomas, thin melanomas sometimes metastasize. Investigators have long sought to uncover prognostic information from histologic sections that would distinguish these higher-risk thin lesions. Histologically apparent regression has been much studied as a risk factor. In this study, the authors (a panel of 10 dermatopathologists with particular expertise in the diagnosis of melanoma) compared 43 patients with primary melanomas less than 1 mm thick (mean, 0.59 mm) who developed metastatic disease and 42 patients matched for age, sex, tumor site, and Breslow thickness who did not develop metastatic disease.

The presence of extensive regression was the only significant histologic difference between the 2 groups. Regression was found in 42% of the patients who developed metastases but in only 5% of the controls. The authors defined regression fairly strictly, although they did allow for some single intraepidermal melanocytic proliferation in regressed sites. The extent of regression was assessed as less than or more than 50% of the entire melanocytic proliferation. The authors concluded that extensive regression in a thin melanoma predicts a higher likelihood of disease progression.

Comment: Regression has been evaluated as an indicator of prognosis for many years with conflicting results, probably resulting from differing definitions of regression. Although the authors attempted to define specific criteria for determining the presence and extent of regression, the criteria remain vague, and the results may not be reproducible outside the study setting. Nonetheless, these findings add to the growing evidence that extensive regression in an otherwise low-risk melanoma is cause for concern. Whether sentinel lymph node biopsy is warranted for patients with these lesions is grounds for a follow-up study.

— Bruce R. Smoller, MD

Published in Journal Watch Dermatology June 26, 2002

Citation(s):

Guitart J et al. Histological characteristics of metastasizing thin melanomas: A case-control study of 43 cases. Arch Dermatol 2002 May; 138:603-8.

Your Remark:

Reader Remarks are intended to encourage lively discussion of clinical topics with your peers in the medical community. Please consider this when composing your remark.

Fields marked with an * are required.

Name as you'd like it to appear:

Submitting a comment indicates you have read and agreed to the remark guidelines and declare:*

PRIVACY: We will not use your email address, submitted for a comment, for any other purpose nor sell, rent, or share your e-mail address with any third parties. Please see our Privacy Policy.

 

CLEAR erases anything you've added in any part of the form. CONTINUE allows you to check your entire post (and edit it if necessary) before submitting.

To ensure that your Reader Remark is not formatted as one long paragraph, precede new paragraphs with either a blank line or an indentation.

Search

Advanced

Article Tools

Reader Remarks

Sign-In

Forgot your password?

New to Journal Watch?

E-mail Alerts

Delivered to your inbox.
Tailored to your interests. Free.

Sign Up Now!

Journal Watch Newsletters

Available in 13 specialties with convenient delivery and 10 free online CME exams.

Subscribe Now!

Copyright © 2002. Massachusetts Medical Society. All rights reserved.